Meso Numismatics, a Renowned Leader in Regenerative Medical, Announces Global Stem Cells Groups (GSCG) Launch of Revolutionary New Line of Peptides
LAS VEGAS, NV, Aug. 13, 2024 (GLOBE NEWSWIRE) — Meso Numismatics, Inc. (“Meso Numismatics” or the “Company”) (MSSV), a renowned leader in regenerative medical company, and in the process with FINRA of a name change to Regenerative Medical Technology Group, is pleased to announce Global Stem Cells Group’s (GSCG) launch of its innovative Cellgenic peptide line. Cellgenic, the division of GSCG that promotes and distributes innovative products and equipment for physicians in the field of regenerative medicine, introduces this new line of peptides, once again solidifying its mission to provide physicians with cutting-edge solutions to improve patient care.